Nigericin Fermentation Yield Optimization via Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing nigericin from Streptomyces result in low yields and high production costs, with nigericin often being obtained as a byproduct or contaminant during fermentation processes, lacking a defined process for exclusive and efficient production.
Innovation Solution
A fermentation process involving Streptomyces sp. MCC 0151, where the bacteria are cultured in a metabolite production medium, mixed with ethyl acetate, centrifuged, and purified using column chromatography to achieve a high yield of nigericin as the main product, with a yield of up to 500 mg/L and 33% by weight.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional fermentation processes are used to produce nigericin, then production can proceed with existing methods, but the yield is low and production cost is high
Solution Approach 1:
The patent optimizes fermentation parameters including pH (maintained at 6.5-7.5), temperature (25-30°C), aeration rate (1-2 vvm), and agitation speed (200-400 rpm) to maximize nigericin yield. The medium composition is also optimized with specific carbon sources (glucose 20g/L, starch 30g/L) and nitrogen sources (yeast extract 5g/L, peptone 10g/L) to enhance productivity while controlling costs
2Productivity
If nigericin is obtained as a byproduct during geldanamycin fermentation, then existing fermentation infrastructure can be utilized, but the production is not exclusive and yield is limited
Solution Approach 1:
The patent employs selective extraction methods to isolate nigericin from the fermentation broth. Ethyl acetate extraction is used to separate nigericin from other metabolites, followed by column chromatography on silica gel to achieve pure nigericin. This extraction approach enables exclusive nigericin production from the fermentation process
Solution Approach 2:
Instead of obtaining nigericin as a contaminant during geldanamycin production, the patent inverts the approach by specifically optimizing fermentation conditions to make nigericin the primary desired product, with geldanamycin production minimized or eliminated through selective medium composition and process parameters
3Adaptability or versatility
If only a few global fermentation industries produce nigericin commercially, then existing production can be maintained, but availability is limited and cost is exorbitant
Solution Approach 1:
The patent develops a complete self-contained production system including strain selection (Streptomyces sp. producing nigericin), optimized medium formulation, fermentation process parameters, and downstream processing methods. This integrated approach enables independent commercial production without relying on a few existing suppliers, thereby increasing availability and reducing costs
4Manufacturing precision
If complex purification processes are used to isolate nigericin, then high purity can be achieved, but the process complexity increases
Solution Approach 1:
The patent uses ethyl acetate as an intermediary solvent for extraction, which selectively dissolves nigericin from the fermentation broth. This is followed by column chromatography using silica gel as a stationary phase and a gradient of dichloromethane-methanol as mobile phase. These intermediary materials facilitate efficient separation and purification while maintaining manageable process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process effectively produces nigericin as the primary metabolite with high yield and purity, demonstrating antibacterial and anti-malarial properties, and is economically viable for industrial-scale production.
Implementation Method 1
mixing the metabolite production medium containing the Streptomyces sp. MCC 0151 cells and ethyl acetate in a ratio of 1:1 to obtain a mixture
Implementation Method 2
centrifuging the mixture obtained in step (ii) to obtain a supernant and an ethyl acetate extract comprising nigericin
Implementation Method 3
evaporating the ethyl acetate extract obtained in step (iii) to obtain a dried crude extract
Implementation Method 4
purifying the dried crude extract obtained in step (iv) by column chromatography to obtain a purified nigericin
Data Source
AI summary
A fermentation process is provided for the synthesis of Nigericin from Streptomyces sp. having accession number MCC 0151 and its isolation with high yield. A microbial inoculant composition is provided, comprising a biologically pure culture of Streptomyces sp. MCC 0151 for the exclusive production of Nigericin with high yield.